Washington -- A research study funded by the National Institutes of Health reveals a new treatment for the canine form of muscular dystrophy that could help treat the human form of the disease.
Washington
-- A research study funded by the National Institutes of Health reveals a new treatment for the canine form of muscular dystrophy that could help treat the human form of the disease.
Published online in the Annals of Neurology, the study found that, using a genetic technology called "exon skipping," scientists could use pieces of DNA-like molecules and apply them as patches to cover up mutant DNA sequences. The dog's body can then make a functional version of the muscle protein affected by Duchenne muscular dystrophy.
The same gene is affected in the human form of the disease.
The study was conducted by Dr. Toshifumi Yokota and Dr. Eric Hoffman of Children's National Medical Center in Washington, D.C., and Dr. Shin'ichi Takeda of the National Center of Neurology and Psychology in Tokyo, as well as researchers at Children's, Carolinas Medical Center in Charlotte, N.C., and the National Center in Japan.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 1
May 17th 2024David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.
Listen
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More